These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33785689)

  • 1. Adaptation of the Flu-FIT Program for Patient-Aligned Care Teams: A Quality Improvement Project.
    Funes SA; Flores C; Davidow AL; Friedman S; Korenblit P; Thomas P
    J Public Health Manag Pract; 2021 May-Jun 01; 27(Suppl 3):S159-S163. PubMed ID: 33785689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FLU-FIT program: an effective colorectal cancer screening program for high volume flu shot clinics.
    Potter MB; Somkin CP; Ackerson LM; Gomez V; Dao T; Horberg MA; Walsh J ME
    Am J Manag Care; 2011; 17(8):577-83. PubMed ID: 21851145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Offering annual fecal occult blood tests at annual flu shot clinics increases colorectal cancer screening rates.
    Potter MB; Phengrasamy L; Hudes ES; McPhee SJ; Walsh JM
    Ann Fam Med; 2009; 7(1):17-23. PubMed ID: 19139445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of the FLU-FOBT program in primary care a randomized trial.
    Potter MB; Walsh JM; Yu TM; Gildengorin G; Green LW; McPhee SJ
    Am J Prev Med; 2011 Jul; 41(1):9-16. PubMed ID: 21665058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders.
    Baldwin LM; Schneider JL; Schwartz M; Rivelli JS; Green BB; Petrik AF; Coronado GD
    BMC Health Serv Res; 2020 Feb; 20(1):132. PubMed ID: 32085767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Fecal Immunochemical Testing Rates for Colon Cancer Screening in the Outpatient Setting.
    Hussain W; Aurand W; Onuorah N; Krstevski G; Markert R; Springer K; Agrawal S
    South Med J; 2021 Feb; 114(2):77-80. PubMed ID: 33537787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact on healthcare resources of switch from fecal occult blood test to fecal immunochemical test within the English Bowel Cancer Screening Program: a single-center study.
    Pelitari S; Gautham A; Mistry P; Mohan S; Brookes M; McKaig B; Shah A; Jewes S; Fieldhouse G; Veitch A; Murugananthan A
    Gastrointest Endosc; 2021 Sep; 94(3):598-606. PubMed ID: 33727015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial.
    Denters MJ; Deutekom M; Bossuyt PM; Fockens P; Dekker E
    Eur J Cancer Prev; 2013 Jul; 22(4):299-304. PubMed ID: 23169243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a home-based colorectal cancer screening intervention in a rural state.
    Charlton ME; Mengeling MA; Halfdanarson TR; Makki NM; Malhotra A; Klutts JS; Levy BT; Kaboli PJ
    J Rural Health; 2014; 30(3):322-32. PubMed ID: 24164375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of two pharmacy-based colorectal cancer screening interventions during an annual influenza vaccination campaign.
    Potter MB; Gildengorin G; Wang Y; Wu M; Kroon L
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):181-7. PubMed ID: 20199960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
    Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
    Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.
    Kooyker AI; Toes-Zoutendijk E; Opstal-van Winden AWJ; Spaander MCW; Buskermolen M; van Vuuren HJ; Kuipers EJ; van Kemenade FJ; Ramakers C; Thomeer MGJ; Dekker E; Nagtegaal ID; de Koning HJ; van Leerdam ME; Lansdorp-Vogelaar I
    Int J Cancer; 2020 Aug; 147(4):1098-1106. PubMed ID: 31853977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial.
    Potter MB; Ackerson LM; Gomez V; Walsh JM; Green LW; Levin TR; Somkin CP
    Am J Public Health; 2013 Jun; 103(6):1128-33. PubMed ID: 23597357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a continuum of hybrid effectiveness-implementation studies to put research-tested colorectal screening interventions into practice.
    Green BB; Coronado GD; Schwartz M; Coury J; Baldwin LM
    Implement Sci; 2019 May; 14(1):53. PubMed ID: 31142348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Immunochemical Test: The World's Colorectal Cancer Screening Test.
    Robertson DJ; Selby K
    Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):511-526. PubMed ID: 32439085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.